Tower Trust & Investment CO Biogen Inc. Transaction History
Tower Trust & Investment CO
- $141 Billion
- Q2 2025
A detailed history of Tower Trust & Investment CO transactions in Biogen Inc. stock. As of the latest transaction made, Tower Trust & Investment CO holds 2,895 shares of BIIB stock, worth $449,448. This represents 0.26% of its overall portfolio holdings.
Number of Shares
2,895
Previous 2,727
6.16%
Holding current value
$449,448
Previous $330 Million
10.12%
% of portfolio
0.26%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,019Shares Held
131MCall Options Held
2.87MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.68 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.45 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.26 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.16 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$745 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...